Recruiting Hidradenitis Suppurativa Studies in Portland
Descemet Endothelial Thickness Comparison Trial I
Descemet Endothelial Thickness Comparison Trial (DETECT) I is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 160 patients in a 2x2 factorial design. The purpose...
Descemet Endothelial Thickness Comparison Trial II
Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DM...
About Hidradenitis Suppurativa Clinical Trials in Portland
Hidradenitis suppurativa is a chronic skin condition causing painful lumps under the skin, typically in areas where skin rubs together. It can lead to tunnels under the skin and scarring. Treatment includes antibiotics, biologics, and surgical interventions.
There are currently 2 hidradenitis suppurativa clinical trials recruiting participants in Portland, OREGON. These studies are seeking a combined 220 participants. Research is being sponsored by Stanford University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hidradenitis Suppurativa Clinical Trials in Portland — FAQ
Are there hidradenitis suppurativa clinical trials in Portland?
Yes, there are 2 hidradenitis suppurativa clinical trials currently recruiting in Portland, OREGON. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Portland?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Portland research site will contact you about next steps.
Are clinical trials in Portland free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Portland studies also compensate for your time and travel.
What hidradenitis suppurativa treatments are being tested?
The 2 active trials in Portland are testing new therapies including novel drugs, biologics, and treatment approaches for hidradenitis suppurativa.
Data updated March 2, 2026 from ClinicalTrials.gov